Figures & data
Table 1. Reimbursed cost for SHPT drugs.
Table 2. Demographic characteristics.
Table 3. Biochemical parameters.
Table 4. Average dosages and weekly cost of treating SHPT.
Figure 1. Percentage of patients at target levels of biochemical parameters.
Table 5. Total population FARO project: average dosages for patients with a determined treatment at least in one survey.
Table 6. Association group: average dosages in selected patients compared with incident patients at second and third survey.
Table 7. Cost analysis (for calcium based P binders and Sevelamer) in patients treated with Paricalcitol alone or in combination with Cinacalcet.